Skip to content
akaturk Academic measurement
  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Nöroloji
Academic summary YÖKSİS and OpenAlex counted separately.
Articles 73
YÖKSİS73 OpenAlex0
Projects 12
Books 9
Proceedings 37

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 48
h-index 12 Percentile in Türkiye: 90 #195 of 2,128 at their university by h-index
i10-index
16
Total citations
2,153
Top 1.4% in Türkiye
Per article
44.9
FWCI
3.10
1.00 = world average
World top 1%
2
World top 10%
4

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included.

Field ranking

YÖKSİS ?

Index quartiles

?
Scopus (SJR) 54
  • Q1 17 %31.5
  • Q2 16 %29.6
  • Q3 13 %24.1
  • Q4 8 %14.8
WoS (JCR) 54
  • Q1 13 %24.1
  • Q2 9 %16.7
  • Q3 14 %25.9
  • Q4 18 %33.3
TR Index 15 articles
OpenAlex citation percentile
Top 1%2
Top 10%5
Avg · n 70 %60.3
Other counts

Scopus (SJR)

  • YÖKSİS rows 76

WoS (JCR)

  • YÖKSİS rows 76

TR Index

  • YÖKSİS rows 18 articles

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

73articles

Journals with publications

39 journals

Narrow down

Scopus (SJR)
WoS (JCR)
TR Index

Article filter applied. Journal filter: The Lancet Neurology Clear filter ×

Article list

1 / 73 articles

  1. 2024 Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials LANCET NEUROLOGY DOI 10.1016/ S1474-4422(24)00328-4 YÖKSİS SJR Q1 JCR Q1

← Back to academicians